Back to search

Risk of new-onset diabetes in the Losartan Intervention For Endpoint reduction in hypertension study

Data up to Jan 2025

Published2002
Citations403
References25

Total Citations Per Year

Abstract

References (25)

Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy

2001 • 7,165 citations

Global and societal implications of the diabetes epidemic

2001 • 5,825 citations

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

2002 • 5,471 citations

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy

2000 • 3,103 citations

Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial

1999 • 2,051 citations

Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

2002 • 1,592 citations

Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study

1999 • 1,472 citations

Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT)

2000 • 1,224 citations

Randomised trial of effects of calcium antagonists compared with diuretics and β-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study

2000 • 923 citations

Diabetes risk score: towards earlier detection of Type 2 diabetes in general practice

2000 • 378 citations

Prevalence and Determinants of Glucose Intolerance in a Dutch Caucasian Population: The Hoorn Study

1995 • 329 citations

Discussion

1997 • 315 citations

A Clinical Approach for the Diagnosis of Diabetes Mellitus

1996 • 304 citations

Characteristics of 9194 Patients With Left Ventricular Hypertrophy

1998 • 296 citations

A clinical approach for the diagnosis of diabetes mellitus: an analysis using glycosylated hemoglobin levels. Meta-analysis Research Group on the Diagnosis of Diabetes Using Glycated Hemoglobin Levels

1996 • 245 citations

Reduced Cardiovascular Morbidity and Mortality in Hypertensive Diabetic Patients on First-Line Therapy With an ACE Inhibitor Compared With a Diuretic/β-Blocker–Based Treatment Regimen

2001 • 222 citations

Comparison of antihypertensive treatments in preventing cardiovascular events in elderly diabetic patients

2000 • 202 citations

H35 Baseline characteristics of the life (Losartan intervention for endpoint reduction) in hypertension study

1997 • 186 citations

No excess 12-year mortality in men with impaired glucose tolerance who participated in the Malm� Preventive Trial with diet and exercise

1998 • 183 citations

Separate and joint effects of systemic hypertension and diabetes mellitus on left ventricular structure and function in American Indians (the Strong Heart Study)

2001 • 160 citations

Increasing prevalence of diabetes mellitus and impaired glucose tolerance among 60‐year‐old Danes

2001 • 134 citations

Screening for diabetes in general practice: cross sectional population study

2001 • 113 citations

A Model for Early Diagnosis of Type 2 Diabetes Mellitus in Primary Health Care

1993 • 66 citations

Lowering of blood pressure and predictors of response in patients with left ventricular hypertrophy: The LIFE study

2000 • 60 citations

Prediction of diabetes with body mass index, oral glucose tolerance test and islet cell autoantibodies in a regional population

2001 • 42 citations

Cited By (0)

No citing papers found in database

Risk of new-onset diabetes in the Losartan Intervention For Endpoint reduction in… (2002) – Journal of Hypertension | Metascience Observatory Explorer